-
1
-
-
55249105923
-
Clostridium difficile-more difficult than ever
-
Kelly CP, LaMont JT (2008) Clostridium difficile-more difficult than ever. New England Journal of Medicine 359 (18): 1932-40.
-
(2008)
New England Journal of Medicine
, vol.359
, Issue.18
, pp. 1932-1940
-
-
Kelly, C.P.1
LaMont, J.T.2
-
2
-
-
65449155189
-
Clostridium difficile infection caused by the epidemic bi/nap1/027 strain
-
O'Connor JR, Johnson S, Gerding DN (2009) Clostridium difficile infection caused by the epidemic BI/NAP1/027 strain. Gastroenterology 136 (6): 1913-24.
-
(2009)
Gastroenterology
, vol.136
, Issue.6
, pp. 1913-1924
-
-
O'Connor, J.R.1
Johnson, S.2
Gerding, D.N.3
-
3
-
-
25144469664
-
Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe
-
Warmy M, Pepin J, Fang A, Killgore G, Thompson A, et al. (2005) Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 366: 9491.
-
(2005)
Lancet
, vol.366
, pp. 9491
-
-
Warmy, M.1
Pepin, J.2
Fang, A.3
Killgore, G.4
Thompson, A.5
-
4
-
-
0036129083
-
Morbidity, mortality, and healthcare burden of nosocomial Clostridium difficile-associated diarrhea iMorbidity, mortality, and healthcare burden of nosocomial Clostridium difficile-associated diarrhea in Canadian hospitals
-
Miller MA, Hyland M, Ofner-Agostini M, Gourdeau M, Ishak M, et al Canadian Hospital Epidemiology Committee. Canadian Nosocomial Infection Surveillance. (2002) Morbidity, mortality, and healthcare burden of nosocomial Clostridium difficile-associated diarrhea iMorbidity, mortality, and healthcare burden of nosocomial Clostridium difficile-associated diarrhea in Canadian hospitals. Infect Control Hosp Epidemiol 23 (3): 137-40.
-
(2002)
Infect Control Hosp Epidemiol
, vol.23
, Issue.3
, pp. 137-140
-
-
Miller, M.A.1
Hyland, M.2
Ofner-Agostini, M.3
Gourdeau, M.4
Ishak, M.5
Canadian Nosocomial Infection Surveillance6
-
5
-
-
38049084783
-
Update on the changing epidemiology of clostridium difficile-associated disease
-
McFarland LV (2008) Update on the changing epidemiology of Clostridium difficile-associated disease. Nat Clin Pract Gastroenterol Hepatol 5 (1): 40-8.
-
(2008)
Nat Clin Pract Gastroenterol Hepatol
, vol.5
, Issue.1
, pp. 40-48
-
-
McFarland, L.V.1
-
6
-
-
39749120072
-
Antimicrobial-associated risk factors for Clostridium difficile infection
-
Owens RC Jr, Donskey CJ, Gaynes RP, Loo VG, Muto CA (2008) Antimicrobial-associated risk factors for Clostridium difficile infection. Clin Infect Dis 46 (Suppl 1): S19-31.
-
(2008)
Clin Infect Dis
, vol.46
, pp. S19-S31
-
-
Owens, R.C.1
Donskey, C.J.2
Gaynes, R.P.3
Loo, V.G.4
Muto, C.A.5
-
7
-
-
60349093694
-
Predictors of serious complications due to clostridium difficile infection
-
Gujja D, Friedenberg FK (2009) Predictors of serious complications due to Clostridium difficile infection. Aliment Pharmacol Ther 29 (6): 635-42.
-
(2009)
Aliment Pharmacol Ther
, vol.29
, Issue.6
, pp. 635-642
-
-
Gujja, D.1
Friedenberg, F.K.2
-
8
-
-
0036845101
-
Underlying disease severity as a major risk factor for nosocomial clostridium difficile diarrhea
-
Kyne L, Sougioultzis S, McFarland LV, Kelly CP (2002) Underlying disease severity as a major risk factor for nosocomial Clostridium difficile diarrhea. Infect Control Hosp Epidemio 23(11): 653-9.
-
(2002)
Infect Control Hosp Epidemio
, vol.23
, Issue.11
, pp. 653-659
-
-
Kyne, L.1
Sougioultzis, S.2
McFarland, L.V.3
Kelly, C.P.4
-
9
-
-
0031752883
-
Risk factors for clostridium difficile infection
-
Bignardi GE (1998) Risk factors for Clostridium difficile infection. J Hosp Infect 40: 1-15.
-
(1998)
J Hosp Infect
, vol.40
, pp. 1-15
-
-
Bignardi, G.E.1
-
10
-
-
0020062279
-
Antibiotic-associated pseudomembranous colitis: An epidemiologic investigation of a cluster of cases
-
Pierce PF Jr, Wilson R, Silva J Jr, Garagusi VF, Rifkin GD, et al. (1982) Antibiotic-associated pseudomembranous colitis: an epidemiologic investigation of a cluster of cases. J Infect Dis 145: 269-74.
-
(1982)
J Infect Dis
, vol.145
, pp. 269-274
-
-
Pierce, P.F.1
Wilson, R.2
Silva, J.3
Garagusi, V.F.4
Rifkin, G.D.5
-
11
-
-
44849131030
-
Overuse and inappropriate prescribing of proton pump inhibitors in patients with Clostridium difficileassociated disease
-
Choudhry MN, Soran H, Ziglam HM (2008) Overuse and inappropriate prescribing of proton pump inhibitors in patients with Clostridium difficileassociated disease. QJM. 101 (6): 445-8.
-
(2008)
QJM
, vol.101
, Issue.6
, pp. 445-448
-
-
Choudhry, M.N.1
Soran, H.2
Ziglam, H.M.3
-
12
-
-
48749087340
-
Is over-use of proton pump inhibitors fuelling the current epidemic of clostridium difficile-associated diarrhoea?
-
Cunningham R, Dial S (2008) Is over-use of proton pump inhibitors fuelling the current epidemic of Clostridium difficile-associated diarrhoea? J Hosp Infect 70 (1): 1-6.
-
(2008)
J Hosp Infect
, vol.70
, Issue.1
, pp. 1-6
-
-
Cunningham, R.1
Dial, S.2
-
13
-
-
84892373793
-
Inappropriate Use of Gastric Acid Suppression Therapy in Hospitalized Patients with Clostridium difficile-Associated Diarrhea: A Ten-Year Retrospective Analysis
-
Rashid S, Rajan D, Iqbal J, Lipka S, Jacob R, et al. (2012) Inappropriate Use of Gastric Acid Suppression Therapy in Hospitalized Patients with Clostridium difficile-Associated Diarrhea: A Ten-Year Retrospective Analysis. ISRN Gastroenterol: 902320.
-
(2012)
ISRN Gastroenterol
, pp. 902320
-
-
Rashid, S.1
Rajan, D.2
Iqbal, J.3
Lipka, S.4
Jacob, R.5
-
14
-
-
50649112615
-
Gastric acid suppression by proton pump inhibitors as a risk factor for clostridium difficile-associated diarrhea in hospitalized patients
-
Aseeri M, Schroeder T, Kramer J, Zackula R (2008) Gastric acid suppression by proton pump inhibitors as a risk factor for clostridium difficile-associated diarrhea in hospitalized patients. Am J Gastroenterol 103 (9): 2308-13.
-
(2008)
Am J Gastroenterol
, vol.103
, Issue.9
, pp. 2308-2313
-
-
Aseeri, M.1
Schroeder, T.2
Kramer, J.3
Zackula, R.4
-
15
-
-
29144473282
-
Use of gastric acid-suppressive agents and the risk of community-acquired clostridium difficile-associated disease
-
Dial S, Delaney JA, Barkun AN, Suissa S (2005) Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. JAMA 294 (23): 2989-95.
-
(2005)
JAMA
, vol.294
, Issue.23
, pp. 2989-2995
-
-
Dial, S.1
Delaney, J.A.2
Barkun, A.N.3
Suissa, S.4
-
16
-
-
36448981751
-
Association of proton-pump inhibitors with outcomes in clostridium difficile colitis
-
Cadle RM, Mansouri MD, Logan N, Kudva DR, Musher DM (2007) Association of proton-pump inhibitors with outcomes in Clostridium difficile colitis. Am J Health Syst Pharm 64 (22): 2359-63.
-
(2007)
Am J Health Syst Pharm
, vol.64
, Issue.22
, pp. 2359-2363
-
-
Cadle, R.M.1
Mansouri, M.D.2
Logan, N.3
Kudva, D.R.4
Musher, D.M.5
-
17
-
-
60349116490
-
Proton pump inhibitors increase significantly the risk of clostridium difficile infection in a low-endemicity, non-outbreak hospital setting
-
Dalton BR, Lye-Maccannell T, Henderson EA, Maccannell DR, Louie TJ (2009) Proton pump inhibitors increase significantly the risk of Clostridium difficile infection in a low-endemicity, non-outbreak hospital setting. Aliment Pharmacol Ther 29 (6): 626.
-
(2009)
Aliment Pharmacol Ther
, vol.29
, Issue.6
, pp. 626
-
-
Dalton, B.R.1
Lye-Maccannell, T.2
Henderson, E.A.3
Maccannell, D.R.4
Louie, T.J.5
-
18
-
-
84866371914
-
Clostridium difficile infection and proton pump inhibitors
-
Pohl JF (2012) Clostridium difficile infection and proton pump inhibitors. Curr Opin Pediat 24 (5): 627-31.
-
(2012)
Curr Opin Pediat
, vol.24
, Issue.5
, pp. 627-631
-
-
Pohl, J.F.1
-
19
-
-
34547635096
-
Vegetative clostridium difficile survives in room air on moist surfaces and in gastric contents with reduced acidity: A potential mechanism to explain the association between proton pump inhibitors and c. Difficile-associated diarrhea?
-
Jump RL, Pultz MJ, Donskey CJ (2007) Vegetative Clostridium difficile survives in room air on moist surfaces and in gastric contents with reduced acidity: a potential mechanism to explain the association between proton pump inhibitors and C. difficile-associated diarrhea? Antimicrob Agents Chemother 51 (8): 2883-7.
-
(2007)
Antimicrob Agents Chemother
, vol.51
, Issue.8
, pp. 2883-2887
-
-
Jump, R.L.1
Pultz, M.J.2
Donskey, C.J.3
-
20
-
-
27444437759
-
Emergence of fluoroquinolones as the predominant risk factor for clostridium difficile-associated diarrhea: A cohort study during an epidemic in quebec
-
Pépin J, Saheb N, Coulombe MA, Alary ME, Corriveau MP, et al. (2005) Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec. Clin Infect Dis 41 (9): 1254-60.
-
(2005)
Clin Infect Dis
, vol.41
, Issue.9
, pp. 1254-1260
-
-
Pépin, J.1
Saheb, N.2
Coulombe, M.A.3
Alary, M.E.4
Corriveau, M.P.5
-
21
-
-
84908428195
-
Food and Drug (2012) FDA Drug Safety Communication: Clostridium difficile-associated diarrhea can be associated with stomach acid drugs known as proton pump inhibitors (PPIs)
-
Availebl September
-
Administration, U.S. Food and Drug (2012) FDA Drug Safety Communication: Clostridium difficile-associated diarrhea can be associated with stomach acid drugs known as proton pump inhibitors (PPIs). U.S. Food and Drug Administration. Availebl: http://www.fda.gov/Drugs/DrugSafety/ucm290510. htm#sa. Accessed: September 8, 2014.
-
(2014)
U.S. Food and Drug Administration
, vol.8
-
-
Administration, U.S.1
-
22
-
-
77952155563
-
Iatrogenic gastric acid suppression and the risk of nosocomial clostridium difficile infection
-
Howell MD, Novack V, Grgurich P, Soulliard D, Novack L, et al. (2010) Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection. Arch Intern Med 170 (9): 784-90.
-
(2010)
Arch Intern Med
, vol.170
, Issue.9
, pp. 784-790
-
-
Howell, M.D.1
Novack, V.2
Grgurich, P.3
Soulliard, D.4
Novack, L.5
-
23
-
-
84908428194
-
-
UpToDate Accessed September
-
Antibiotics C diff PPI. UpToDate . Available: www.uptodate.com/store. Accessed September 8, 2014.
-
(2014)
, vol.8
-
-
Antibiotics C diff PPI1
-
24
-
-
0023092594
-
A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation
-
Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40 (5): 373-83.
-
(1987)
J Chronic Dis
, vol.40
, Issue.5
, pp. 373-383
-
-
Charlson, M.E.1
Pompei, P.2
Ales, K.L.3
MacKenzie, C.R.4
-
25
-
-
33746413402
-
Proton pump inhibitor therapy is a risk factor for clostridium difficile-associated diarrhoea
-
Yearsley KA, Gilby LJ, Ramadas AV, Kubiak EM, Fone DL, et al. (2006) Proton pump inhibitor therapy is a risk factor for Clostridium difficile-associated diarrhoea. Aliment Pharmacol Ther 24 (4): 613-9.
-
(2006)
Aliment Pharmacol Ther
, vol.24
, Issue.4
, pp. 613-619
-
-
Yearsley, K.A.1
Gilby, L.J.2
Ramadas, A.V.3
Kubiak, E.M.4
Fone, D.L.5
-
26
-
-
81355160270
-
Systematic review: The use of proton pump inhibitors and increased susceptibility to enteric infection
-
Bavishi C, Dupont HL (2011) Systematic review: the use of proton pump inhibitors and increased susceptibility to enteric infection. Aliment Pharmacol Ther 34 (11-12): 1269-81.
-
(2011)
Aliment Pharmacol Ther
, vol.34
, Issue.11-12
, pp. 1269-1281
-
-
Bavishi, C.1
Dupont, H.L.2
-
27
-
-
84896454372
-
Medication risk factors associated with healthcare-associated clostridium difficile infection: A multilevel model case-control study among 64 US academic medical centres
-
Pakyz AL, Jawahar R, Wang Q, Harpe SE (2014) Medication risk factors associated with healthcare-associated Clostridium difficile infection: a multilevel model case-control study among 64 US academic medical centres. J Antimicrob Chemother 69(4):1127-31.
-
(2014)
J Antimicrob Chemother
, vol.69
, Issue.4
, pp. 1127-1131
-
-
Pakyz, A.L.1
Jawahar, R.2
Wang, Q.3
Harpe, S.E.4
-
28
-
-
0034054649
-
Gastric acid suppression does not promote clostridial diarrhoea in the elderly
-
Shah S, Lewis A, Leopold D, Dunstan F, Woodhouse K (2000) Gastric acid suppression does not promote clostridial diarrhoea in the elderly. QJM 93 (3): 175-81.
-
(2000)
QJM
, vol.93
, Issue.3
, pp. 175-181
-
-
Shah, S.1
Lewis, A.2
Leopold, D.3
Dunstan, F.4
Woodhouse, K.5
-
29
-
-
35348853726
-
Fluoroquinolone use and risk factors for Clostridium difficile-associated disease within a veterans Administration health care system
-
McFarland LV, Clarridge JE, Beneda HW, Raugi GJ (2007) Fluoroquinolone use and risk factors for Clostridium difficile-associated disease within a Veterans Administration health care system. Clin Infect Dis 45 (9): 1141-51.
-
(2007)
Clin Infect Dis
, vol.45
, Issue.9
, pp. 1141-1151
-
-
McFarland, L.V.1
Clarridge, J.E.2
Beneda, H.W.3
Raugi, G.J.4
-
30
-
-
78149401686
-
The effect of hospital-acquired clostridium difficile infection on in-hospital mortality
-
Oake N, Taljaard M, van Walraven C, Wilson K, Roth V, et al. (2010) The effect of hospital-acquired Clostridium difficile infection on in-hospital mortality. Arch Intern Med 170 (20): 1804-10.
-
(2010)
Arch Intern Med
, vol.170
, Issue.20
, pp. 1804-1810
-
-
Oake, N.1
Taljaard, M.2
Van Walraven, C.3
Wilson, K.4
Roth, V.5
-
31
-
-
84908462769
-
-
Surawicz CM, Brandt LJ, Binion DG, Ananthakrishnan AN, Curry SR, et al. (2013) Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections.
-
(2013)
Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections
-
-
Surawicz, C.M.1
Brandt, L.J.2
Binion, D.G.3
Ananthakrishnan, A.N.4
Curry, S.R.5
-
32
-
-
84863717616
-
Risk of clostridium difficile infection with acid suppressing drugs and antibiotics: Metaanalysis
-
Kwok CS, Arthur AK, Anibueze CI, Singh S, Cavallazzi R, et al. (2012) Risk of Clostridium difficile infection with acid suppressing drugs and antibiotics: metaanalysis. Am J Gastroenterol 107(7):1011-9.
-
(2012)
Am J Gastroenterol
, vol.107
, Issue.7
, pp. 1011-1019
-
-
Kwok, C.S.1
Arthur, A.K.2
Anibueze, C.I.3
Singh, S.4
Cavallazzi, R.5
|